Explainer: Making a new generation of 'guided-missile' cancer drugs work

A class of treatments known as antibody-drug conjugates (ADC) combine cancer-tracking proteins with powerful cell toxins. The therapies are getting a fresh start as dozens of drugmakers test a record number of new compounds in people.

from Reuters: Health News https://ift.tt/2uiRoxb